{
    "N/R/U": null,
    "Applicant": "Novartis Pharmaceuticals Corporation",
    "BLA Number": "125646",
    "Proprietary Name": "Kymriah",
    "Proper Name": "tisagenlecleucel",
    "BLA Type": "351(a)",
    "Strength": " 0.6 to 6.0 x 10^8 CAR-POSITIVE VIABLE T CELLS ",
    "Dosage Form": "Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Bag",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "August 30, 2017",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1244",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "May 27, 2029",
    "drug": [
        {
            "name": "tisagenlecleucel",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13881"
        }
    ]
}